#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

NK Cells and γδ T Cells Mediate Resistance to Polyomavirus–Induced Tumors


NK and γδ T cells can eliminate tumor cells in many experimental models, but their effect on the development of tumors caused by virus infections in vivo is not known. Polyomavirus (PyV) induces tumors in neonatally infected mice of susceptible strains and in adult mice with certain immune deficiencies, and CD8+ αβ T cells are regarded as the main effectors in anti-tumor immunity. Here we report that adult TCRβ knockout (KO) mice that lack αβ but have γδ T cells remain tumor-free after PyV infection, whereas TCRβ×δ KO mice that lack all T cells develop tumors. In addition, E26 mice, which lack NK and T cells, develop the tumors earlier than TCRβ×δ KO mice. These observations implicate γδ T and NK cells in the resistance to PyV-induced tumors. Cell lines established from PyV-induced tumors activate NK and γδ T cells both in culture and in vivo and express Rae-1, an NKG2D ligand. Moreover, these PyV tumor cells are killed by NK cells in vitro, and this cytotoxicity is prevented by treatment with NKG2D-blocking antibodies. Our findings demonstrate a protective role for NK and γδ T cells against naturally occurring virus-induced tumors and suggest the involvement of NKG2D-mediated mechanisms.


Vyšlo v časopise: NK Cells and γδ T Cells Mediate Resistance to Polyomavirus–Induced Tumors. PLoS Pathog 6(5): e32767. doi:10.1371/journal.ppat.1000924
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000924

Souhrn

NK and γδ T cells can eliminate tumor cells in many experimental models, but their effect on the development of tumors caused by virus infections in vivo is not known. Polyomavirus (PyV) induces tumors in neonatally infected mice of susceptible strains and in adult mice with certain immune deficiencies, and CD8+ αβ T cells are regarded as the main effectors in anti-tumor immunity. Here we report that adult TCRβ knockout (KO) mice that lack αβ but have γδ T cells remain tumor-free after PyV infection, whereas TCRβ×δ KO mice that lack all T cells develop tumors. In addition, E26 mice, which lack NK and T cells, develop the tumors earlier than TCRβ×δ KO mice. These observations implicate γδ T and NK cells in the resistance to PyV-induced tumors. Cell lines established from PyV-induced tumors activate NK and γδ T cells both in culture and in vivo and express Rae-1, an NKG2D ligand. Moreover, these PyV tumor cells are killed by NK cells in vitro, and this cytotoxicity is prevented by treatment with NKG2D-blocking antibodies. Our findings demonstrate a protective role for NK and γδ T cells against naturally occurring virus-induced tumors and suggest the involvement of NKG2D-mediated mechanisms.


Zdroje

1. ZocchiMR

FerrariniM

MigoneN

CasoratiG

1994 T-cell receptor V delta gene usage by tumour reactive gamma delta T lymphocytes infiltrating human lung cancer. Immunology 81 234 239

2. CorvaisierM

Moreau-AubryA

DiezE

BennounaJ

MosnierJF

2005 V gamma 9V delta 2 T cell response to colon carcinoma cells. J Immunol 175 5481 5488

3. TodaroM

D'AsaroM

CaccamoN

IovinoF

FrancipaneMG

2009 Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 182 7287 7296

4. TakanamiI

TakeuchiK

GigaM

2001 The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 121 1058 1063

5. CocaS

Perez-PiquerasJ

MartinezD

ColmenarejoA

SaezMA

1997 The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 79 2320 2328

6. IshigamiS

NatsugoeS

TokudaK

NakajoA

CheX

2000 Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 88 577 583

7. WelshRM

1984 Natural killer cells and interferon. Crit Rev Immunol 5 55 93

8. PenningerJM

WenT

TimmsE

PotterJ

WallaceVA

1995 Spontaneous resistance to acute T-cell leukaemias in TCRV gamma 1.1J gamma 4C gamma 4 transgenic mice. Nature 375 241 244

9. GirardiM

OppenheimDE

SteeleCR

LewisJM

GlusacE

2001 Regulation of cutaneous malignancy by gammadelta T cells. Science 294 605 609

10. BenjaminTL

2001 Polyoma virus: old findings and new challenges. Virology 289 167 173

11. SwansonPA2nd

LukacherAE

Szomolanyi-TsudaE

2009 Immunity to polyomavirus infection: the polyomavirus-mouse model. Semin Cancer Biol 19 244 251

12. AllisonAC

LawLW

1968 Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med 127 207 212

13. LawLW

TingRC

LeckbandE

1967 Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells. Proc Natl Acad Sci U S A 57 1068 1075

14. AllisonAC

MongaJN

HammondV

1974 Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice. Nature 252 746 747

15. Szomolanyi-TsudaE

WelshRM

1996 T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med 183 403 411

16. LukacherAE

WilsonCS

1998 Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. J Immunol 160 1724 1734

17. LukacherAE

MoserJM

HadleyA

AltmanJD

1999 Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection. J Immunol 163 3369 3378

18. BerkeZ

PalmerS

BergmanT

WesterD

SvedmyrJ

1996 A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity. J Virol 70 3093 3097

19. LukacherAE

MaY

CarrollJP

Abromson-LeemanSR

LaningJC

1995 Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med 181 1683 1692

20. LiunggrenG

LiunggrenHG

DalianisT

1994 T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 198 714 716

21. WangB

BironC

SheJ

HigginsK

SunshineMJ

1994 A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci U S A 91 9402 9406

22. DrakeDR3rd

LukacherAE

1998 Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology 252 275 284

23. McCanceDJ

SebestenyA

GriffinBE

BalkwillF

TillyR

1983 A paralytic disease in nude mice associated with polyoma virus infection. J Gen Virol 64(Pt 1) 57 67

24. Szomolanyi-TsudaE

DundonPL

JorisI

ShultzLD

WodaBA

1994 Acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice. Am J Pathol 144 359 371

25. WilderJA

YuanD

1995 Regulation of IFN-gamma mRNA production in murine natural killer cells. Int Immunol 7 575 582

26. BettsMR

BrenchleyJM

PriceDA

De RosaSC

DouekDC

2003 Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 65 78

27. WatanabeN

HizutaA

TanakaN

OritaK

1995 Localization of T cell receptor (TCR)-gamma delta+T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes. Clin Exp Immunol 102 167 173

28. KowalczykD

SkorupskiW

KwiasZ

NowakJ

1996 Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma. Immunol Lett 53 15 18

29. VieyE

FromontG

EscudierB

MorelY

Da RochaS

2005 Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. J Immunol 174 1338 1347

30. BensussanA

LagabrielleJF

DegosL

1989 TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells. Blood 73 2077 2080

31. ChoudharyA

DavodeauF

MoreauA

PeyratMA

BonnevilleM

1995 Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma. J Immunol 154 3932 3940

32. LozuponeF

PendeD

BurgioVL

CastelliC

SpadaM

2004 Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res 64 378 385

33. KarreK

LjunggrenHG

PiontekG

KiesslingR

1986 Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319 675 678

34. ImaiK

MatsuyamaS

MiyakeS

SugaK

NakachiK

2000 Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356 1795 1799

35. RuggeriL

MancusiA

BurchielliE

AversaF

MartelliMF

2007 Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol 19 142 147

36. BauerS

GrohV

WuJ

SteinleA

PhillipsJH

1999 Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 727 729

37. CerwenkaA

BakkerAB

McClanahanT

WagnerJ

WuJ

2000 Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12 721 727

38. CarayannopoulosLN

NaidenkoOV

FremontDH

YokoyamaWM

2002 Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 169 4079 4083

39. LanierLL

CorlissBC

WuJ

LeongC

PhillipsJH

1998 Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391 703 707

40. WuJ

CherwinskiH

SpiesT

PhillipsJH

LanierLL

2000 DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med 192 1059 1068

41. RosenDB

ArakiM

HamermanJA

ChenT

YamamuraT

2004 A Structural basis for the association of DAP12 with mouse, but not human, NKG2D. J Immunol 173 2470 2478

42. SelinLK

SantolucitoPA

PintoAK

Szomolanyi-TsudaE

WelshRM

2001 Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol 166 6784 6794

43. EagleRA

TrowsdaleJ

2007 Promiscuity and the single receptor: NKG2D. Nat Rev Immunol 7 737 744

44. Szomolanyi-TsudaE

LeQP

GarceaRL

WelshRM

1998 T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J Virol 72 6665 6670

45. DunnGP

OldLJ

SchreiberRD

2004 The three Es of cancer immunoediting. Annu Rev Immunol 22 329 360

46. zur HausenH

2008 Novel human polyomaviruses–re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 123 247 250

47. Szomolanyi-TsudaE

SeedhomMO

CarrollMC

GarceaRL

2006 T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice. Virology 352 52 60

48. WelshRMJr

1978 Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med 148 163 181

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#